EXPERIENCE OF TREATMENT OF JUVENILE POLYARTHRITIS WITH EYES LESION WITH ADALIMUMAB
Abstract
Key words: children, juvenile rheumatoid arthritis, rheumatoid uveitis, adalimumab.
About the Authors
A.O. LisitsinRussian Federation
E.I. Alexeeva
Russian Federation
T.M. Bzarova
Russian Federation
S.I. Valieva
Russian Federation
A.M. Chomakhidze
Russian Federation
K.B. Isaeva
Russian Federation
E.G. Chistyakova
Russian Federation
R.V. Denisova
Russian Federation
E.Yu. Gudkova
Russian Federation
N.A. Karagulyan
Russian Federation
References
1. Cassidy J., Petty R., eds. Textbook of paediatric rheumatology. 2nd end. New York: Churchill Livigstone. 2002.
2. Benеzra D., Cohen E., Maftzir G. Uveitis in children and adolescents. Br. J. Ophthalmol. 2006; 89 (4): 444–448.
3. Foster C. Diagnosis and treatment of juvenile idiopathic arthritis associated uveitis. Current. Opin. Ophthalmol. 2003; 14 (6): 395–398.
4. Arend W., Dayer J. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 1995; 38 (2): 151–160.
5. Beutler B. The role of tumor necrosis factor in health and disease. J. Rheumatol. 1999; 26 (57): 16–21.
6. Хаитов Р.М., Игнатьева Г.А., Сидорович И.Г. Иммунология. М.: Медицина. 2000. 430 с.
7. Danks L., Sabokbar A., Gundle R. et al. Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Ann. Rheum. Dis. 2002; 61 (10): 916–921.
8. Barrera P., Boerbooms A.M., Janssen E.M. et al. Circulating soluble tumor necrosis factor receptors, interleukin–2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum. 1993; 36 (8): 1070–1079.
9. Kalden J. Emerging role of antitumor necrosis factor therapy in rheumatic disease. Arthritis Research. 2002; 4 (Suppl. 2): 34–40.
10. Насонов Е.Л. Фактор некроза опухоли–α — новая мишень для противовоспалительной терапии ревматоидного артрита. Клиническая фармакология и терапия. 2001; 1: 64–70.
11. Lahdenne P., Vahasalo P., Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Annals of Rheumatic Disease. 2003; 62 (3): 245–247.
12. Алексеева Е.И., Алексеева А.М., Бзарова Т.М. и др. Эффективность лечения инфликсимабом резистентных форм ювенильного ревматоидного артрита. Вопросы современной педиатрии. 2006; 5 (2): 20.
13. Насонов Е.Л. Перспективы фармакотерапии воспалительных ревматических заболеваний: моноклональные антитела к фактору некроза опухоли. РМЖ. 2001; 9: 7–9.
14. Furst D., Schiff M., Fleischmann R. et al. Adahmumab, a fully human anti–tumor necrosis factor ᾳ monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis results of STAR (Safety Trial of Adahmumab in Rheumatoid Arthritis). J. Rheumatol. 2003; 30 (12): 2563–2571.
15. Keystone E., Kavanaugh A., Sharp J. et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy a randomized, placebo-controlled, 52-week trial. Arthritis Rheum. 2004; 50 (5): 1400–1411.
16. Mease P., Gladman D., Ritchhn C. et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2005; 52 (10): 3279–3289.
17. Tynjala P., Kotaniemi K., Lindahl P. et al. Adalimumab in the treatment of juvenile idiopathic arthritis associated uveitis – a pilot study. 8th Annual European League Against Rheumatism. Barcelona. 2007. Abstract THU0483.
18. Vazquez-Cobian L.B., Flynn T., Lehman T.J. Adalimumab therapy for childhood uveitis. J. Pediatr. 2006; 149 (4): 572–575.
19. Dana M., Merayo–Lloves J., Schaumberg D., Foster C.S. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997; 104 (2): 236–244.
Review
For citations:
Lisitsin A., Alexeeva E., Bzarova T., Valieva S., Chomakhidze A., Isaeva K., Chistyakova E., Denisova R., Gudkova E., Karagulyan N. EXPERIENCE OF TREATMENT OF JUVENILE POLYARTHRITIS WITH EYES LESION WITH ADALIMUMAB. Current Pediatrics. 2008;7(5):115-120.
Email this article 
